Long-term use of ospemifene in clinical practice for vulvo-vaginal atrophy: end results at 12 months of follow-up. Pingarron Santofimia C, Lafuente Gonzalez P, Guitierrez Velez MDC, Calvente Aguilar V, et al. Gynecol Endocrinol 2022;38:577-582.

Read + Share

Amedeo Smart

Independent Medical Education

Pingarron Santofimia C, Lafuente Gonzalez P, Guitierrez Velez MDC, Calvente Aguilar V, et al. Long-term use of ospemifene in clinical practice for vulvo-vaginal atrophy: end results at 12 months of follow-up. Gynecol Endocrinol 2022;38:577-582.
PMID: 35670533